Tuberculosis

August 25, 2017

Natural product-derived therapy for tuberculosis: β-Cryptoxanthin, isolated from Paprika, Buah Merah, Papaya, Satsuma Mandarin and among others, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 25/August/2017, 11.59 pm

Natural product-derived therapy for tuberculosis: β-Cryptoxanthin, isolated from Paprika, Buah Merah, Papaya, Satsuma Mandarin and among others, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 25/August/2017, 11.59 pm https://genomediscovery.org/wp-content/uploads/2017/08/β-Cryptoxanthin-inhibits-drug-resistant-TB-through-deacetylation-of-RelA.p65.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/08/β-Cryptoxanthin-inhibits-drug-resistant-TB-through-deacetylation-of-RelA.p65.jpg1_.jpg August 25, 2017 August 25, 2017

Introduction: What they say: A study from the Singapore Immunology Network, Agency for Science, Technology and Research, Singapore; and Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore shows…

August 21, 2017

Natural product-derived therapy for tuberculosis: N-Acetylcysteine (NAC) deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 22/August/2017, 1.28 am

Natural product-derived therapy for tuberculosis: N-Acetylcysteine (NAC) deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 22/August/2017, 1.28 am https://genomediscovery.org/wp-content/uploads/2017/08/N-AcetylCysteine-deacetylates-Rela-expression-and-suppresses-drug-resistant-tuberculosis.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/08/N-AcetylCysteine-deacetylates-Rela-expression-and-suppresses-drug-resistant-tuberculosis.jpg August 21, 2017 August 21, 2017

August 15, 2017

Natural product-derived therapy for tuberculosis: Geniposide, isolated from Gardenia, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 15/August/2017, 11.49 pm

Natural product-derived therapy for tuberculosis: Geniposide, isolated from Gardenia, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 15/August/2017, 11.49 pm https://genomediscovery.org/wp-content/uploads/2017/08/Geniposide-increases-sirtuin1-expresion-and-drug-resistant-TB.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/08/Geniposide-increases-sirtuin1-expresion-and-drug-resistant-TB.jpg August 15, 2017 August 15, 2017

July 29, 2017

Molecular Hydrogen therapy for tuberculosis: Hydrogen-rich water deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 29/July/2017, 9.51 pm

Molecular Hydrogen therapy for tuberculosis: Hydrogen-rich water deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 29/July/2017, 9.51 pm https://genomediscovery.org/wp-content/uploads/2017/07/H2-rich-water-inhibits-drug-resistant-tuberculosis-through-up-regulation-of-SIRT1-figure.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/07/H2-rich-water-inhibits-drug-resistant-tuberculosis-through-up-regulation-of-SIRT1-figure.jpg July 29, 2017 July 29, 2017

July 16, 2017

Natural product-derived therapy for tuberculosis: Chenodeoxycholic acid (trade name:Chenodiol) deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 17/July/2017, 12.05 am

Natural product-derived therapy for tuberculosis: Chenodeoxycholic acid (trade name:Chenodiol) deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 17/July/2017, 12.05 am https://genomediscovery.org/wp-content/uploads/2017/07/Chenodiol-inhibits-drug-resistant-TB.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/07/Chenodiol-inhibits-drug-resistant-TB.jpg July 16, 2017 July 16, 2017

July 7, 2017

Vitamin-based therapy for tuberculosis: A form of Vitamin-A deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 7/July/2017, 11.59 pm

Vitamin-based therapy for tuberculosis: A form of Vitamin-A deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 7/July/2017, 11.59 pm https://genomediscovery.org/wp-content/uploads/2017/07/Vitamin-A-inhibits-drug-resistant-TB.jpg1_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2017/07/Vitamin-A-inhibits-drug-resistant-TB.jpg1_.jpg July 7, 2017 July 9, 2017

Popular Post